Cadila Healthcare near deal to buy smaller rival Claris: Report
Cadila Healthcare Ltd, among India`s top ten drugmakers, is in late-stage talks to buy smaller rival Claris Lifesciences Ltd for about 34 billion rupees ($534 million), a financial daily reported on Thursday, citing sources aware of the talks.
May 21, 2015, 10:45 AM IST
Claris gets USFDA supplemental nod for Fluconazole injection
"The company has received the supplemental Abbreviated New Drug Application (ANDA) for Fluconazole injection in the US," Claris Lifesciences said in a filing to the BSE.
Apr 21, 2015, 13:53 PM IST
